Micronized Placental Tissue Compositions for Wound Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical treatments for wound healing and inflammation management lack effective, non-invasive solutions that utilize the therapeutic potential of placental tissue components, particularly the amnion and chorion layers, which are rich in bioactive factors and collagen types.
Innovation Solution
Development of micronized compositions comprising dehydrated amnion and chorion layers, where the amnion layer's epithelium is not substantially removed, formulated into liquids or gels, for topical or injectable applications to enhance wound healing and alleviate joint inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If placental tissue is used for wound healing and inflammation management, then therapeutic effectiveness is improved through delivery of bioactive factors and collagen, but the complexity of preparing and formulating the tissue into usable compositions increases
Solution Approach 1:
The placental tissue is segmented into distinct micronized particles of amnion and chorion layers, each retaining their unique bioactive properties. This segmentation allows for standardized processing and formulation while preserving the therapeutic components in a manageable particle form that can be easily incorporated into various delivery systems.
Solution Approach 2:
The tissue undergoes controlled dehydration and micronization processes that change its physical parameters (moisture content, particle size) while preserving its biochemical integrity. These parameter changes transform the fresh tissue into a stable, shelf-ready formulation that maintains therapeutic effectiveness without requiring complex cold chain storage or preparation infrastructure.
2Stability of the object's composition
If the amnion layer is dehydrated and micronized, then the composition becomes more stable and easier to formulate, but the epithelium layer may be damaged or lost
Solution Approach 1:
The epithelium layer is identified and protected as a critical component before the dehydration and micronization processes begin. Processing parameters are pre-optimized to ensure the epithelium survives the transformation, and quality control measures are implemented at each stage to verify epithelial integrity is maintained throughout formulation.
Solution Approach 2:
The dehydration process uses carefully controlled parameters (temperature, humidity, time) that achieve composition stability without exceeding thresholds that would damage the epithelium. The micronization process similarly uses optimized mechanical stress levels that reduce particle size while preserving the delicate epithelial structures within the particles.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The micronized compositions provide enhanced wound healing, reduce inflammation, and promote tissue regeneration by delivering bioactive factors directly to the site of application, improving tissue repair and minimizing scarring.
Implementation Method 1
the micronized particles have an average particle size of from 25 μm to 150 μm
Implementation Method 2
said particles comprising a dehydrated amnion layer and a dehydrated chorion layer
Data Source
Figure 1
AI summary
Described herein are composition composed of micronized placental components and pharmaceutical compositions thereof The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein.